Evaluation of four qualitative third-generation HIV antibody assays and the fourth-generation abbott HIV Ag/Ab combo test

Laboratory Medicine

Volumn 42, Issue 9, 2011, Pages 523-535

  Wians, Frank H ^a   Moore, Holly A ^a   Briscoe, Donna ^a   Anderson, Kathy M ^a   Hicks, Pamela S ^b   Smith, Debbie L ^b   Clark, Tammy A ^c   Preston, Maggie M ^d   Gammons, Beckie ^d   Ray, Cynthia S ^e   Bond, Christine ^f   West, Joshua T ^g  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Pathology   (United States)

^c Baylor All Saints ^*  (United States)

^d PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^e Texas Health Harris Methodist Hospital   (United States)

^f Texas Health Presbyterian Hospital   (United States)

^g Texas Health Harris Methodist Hospital Southwest   (United States)

Author keywords

Agreement; Comparative method; Fourth generation assay; Human immunodeficiency virus; Test method

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ARTICLE; COMBO TEST; CONTROLLED STUDY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCREENING TEST; VIRUS DETECTION; VIRUS LOAD; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052642548     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM38NCGQ0GWJIMZV     Document Type: Article

References (25)

1. Marquez C, Zetola NM, Klausner JD. HIV testing: An update. MLO Med Lab Obs. 2008;40:12-14,16,18 passim.
2. Global report: UNAIDS report on the global AIDS epidemic 2010. ISBN 978-92-9173-871-7 (NLM classification: WC 503.4).
3. Anderson BL, Cu-Uvin S. Pregnancy and optimal care of HIV-infected patients. Clin Infect Dis. 2009;48:449-455.
4. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
5. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17:1871-1879.
6. Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol. 2008;46:1588-1595.
7. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009;49:2454-2489.
8. Patel P, Mackellar D, Simmons P, et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med. 2010;170:66-74.
9. Pumarola T, Freeman J, Saxton E, et al. Performance evaluation of the ADVIA Centaur HIV Ag/Ab Combo assay. J Virol Methods. 2010;170:16-20.
10. Schappert J, Wians FH Jr, Schiff E, et al. Multicenter evaluation of the Bayer ADVIA Centaur HIV 1/O/2 enhanced (EHIV) assay. Clin Chim Acta. 2006;372:158-166.
11. Thompson MP, Hidalgo D, Kim A, et al. The VITROS immunodiagnostics products anti-HIV 1+2 assay: A rapid and reliable method for HIV screening. LabMed. 2011;42:209-212.
12. Delaney KP, Branson BM, Uniyal A, et al. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis. 2011;52:257-263.
13. CLSI. User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline. 2nd ed. EP12-A2. Wayne, PA: CLSI; 2008;28:1-46.
14. Pandori MW, Hackett J Jr, Louie B, et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol. 2009;47:2639-2642.
15. Speers D, Phillips P, Dyer J. Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window. J Clin Microbiol. 2005;43:5397-5399.
16. Centers for Disease Control. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2008. HIV Surveillance Report. 2008;20:1-143.
17. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a high-incidence population: Is antibody testing alone good enough? Clin Infect Dis. 2009;49:444-453.
18. Eshleman SH, Khaki L, Laeyendecker O, et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr. 2009;52:121-124.
19. Ly TD, Laperche S, Brennan C, et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods. 2004;122:185-194.
20. Kang HJ, Yoo KH, Kim HS, et al. [Evaluation of Abbott Fourth Generation HIV Antigen and Antibody Assays.]. [Korean] Korean J Lab Med. 2006;26:39-44.
21. Weber B. A new automated fourth-generation HIV screening assay with sensitive antigen detection module and high specificity. In: Zhu T, ed. Methods in Molecular Biology vol. 304. Human Retrovirus Protocols: Virology and Molecular Biology. Totowa, NJ: Humana Press.
22. Shields M. HIV seroconversion illness-Latest HIV assays may still be negative. Aust Fam Physician. 2006;35:523-525.
23. Stekler JD, Swenson PD, Coombs RW, et al. HIV testing in a high-incidence population: Is antibody testing alone good enough? Clin Infect Dis. 2009;49:444-453.
24. CDC American Public Health Laboratories (APHL) HIV Diagnostics Conference, 2010.
25. Technical Series of the Tulip Group: HIV testing: Evolution and practical issues. Goa, India: Qualpro Diagnostics, www.tulipgroup.com.